SG11201706693QA - Methods of treating infertility - Google Patents

Methods of treating infertility

Info

Publication number
SG11201706693QA
SG11201706693QA SG11201706693QA SG11201706693QA SG11201706693QA SG 11201706693Q A SG11201706693Q A SG 11201706693QA SG 11201706693Q A SG11201706693Q A SG 11201706693QA SG 11201706693Q A SG11201706693Q A SG 11201706693QA SG 11201706693Q A SG11201706693Q A SG 11201706693QA
Authority
SG
Singapore
Prior art keywords
methods
treating infertility
infertility
treating
Prior art date
Application number
SG11201706693QA
Inventor
Saez Joan Carlos Arce
Jane Ruman
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Bv filed Critical Ferring Bv
Publication of SG11201706693QA publication Critical patent/SG11201706693QA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/24Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/42Gynaecological or obstetrical instruments or methods
    • A61B17/425Gynaecological or obstetrical instruments or methods for reproduction or fertilisation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0603Embryonic cells ; Embryoid bodies
    • C12N5/0604Whole embryos; Culture medium therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0608Germ cells
    • C12N5/0609Oocytes, oogonia
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Surgery (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
SG11201706693QA 2015-02-26 2016-02-25 Methods of treating infertility SG11201706693QA (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201562121131P 2015-02-26 2015-02-26
US201562121113P 2015-02-26 2015-02-26
EP15157661 2015-03-04
EP15185191 2015-09-15
PCT/EP2016/053934 WO2016135221A1 (en) 2015-02-26 2016-02-25 Methods of treating infertility

Publications (1)

Publication Number Publication Date
SG11201706693QA true SG11201706693QA (en) 2017-09-28

Family

ID=56787937

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201706693QA SG11201706693QA (en) 2015-02-26 2016-02-25 Methods of treating infertility

Country Status (25)

Country Link
US (4) US10413592B2 (en)
EP (2) EP3261661B1 (en)
JP (2) JP7163027B2 (en)
KR (1) KR102618298B1 (en)
CN (2) CN107257690A (en)
AU (1) AU2016223496B2 (en)
CA (1) CA2976032A1 (en)
DK (1) DK3261661T3 (en)
ES (1) ES2968102T3 (en)
FI (1) FI3261661T3 (en)
HK (1) HK1246655A1 (en)
HR (1) HRP20240013T1 (en)
HU (1) HUE064604T2 (en)
LT (1) LT3261661T (en)
MA (1) MA41758B1 (en)
MD (1) MD3261661T2 (en)
MX (1) MX2017010320A (en)
PH (1) PH12017501493A1 (en)
PL (1) PL3261661T3 (en)
RS (1) RS65096B1 (en)
RU (1) RU2723098C2 (en)
SG (1) SG11201706693QA (en)
SI (1) SI3261661T1 (en)
WO (1) WO2016135221A1 (en)
ZA (1) ZA201705489B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2016223496B2 (en) 2015-02-26 2021-09-09 Ferring B.V. Methods of treating infertility
EP3675894B1 (en) 2017-09-01 2021-11-03 Ferring B.V. Composition for controlled ovarian stimulation
CN109602394B (en) * 2018-12-12 2020-01-17 北京大学第三医院 System for assessing ovarian reserve function of a subject
CN110491505B (en) * 2019-08-22 2021-06-01 北京大学第三医院(北京大学第三临床医学院) System for predicting the number of oocytes obtained during ovarian stimulation of a subject
TW202210096A (en) * 2020-05-29 2022-03-16 荷蘭商菲林公司 Methods of treating infertility
EP3932419A1 (en) * 2020-06-29 2022-01-05 Ferring B.V. Methods of treating infertility
KR20230028368A (en) * 2020-06-26 2023-02-28 훼링 비.브이. HP-HMG for use in the treatment of infertility in patients with polycystic ovary syndrome
KR102498267B1 (en) 2021-01-13 2023-02-13 주식회사 아이웍스 Rotating injection assembly comprising microbubble-generated mixed aerator

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4725579A (en) * 1985-02-21 1988-02-16 Serono Laboratories, Inc. Method of in vitro fertilization by a unique combination of gonadotropins
WO2000063248A2 (en) 1999-04-16 2000-10-26 Instituto Massone S.A. Highly purified gonadotropin compositions and process for preparing them
DK1425033T3 (en) * 2001-09-12 2011-01-10 Merck Serono Sa Use of hCG and LH in controlled ovarian stimulation
US20140235540A1 (en) * 2008-05-20 2014-08-21 Norbert Gleicher Androgen and gonadotropin treatment in females
RU2466724C1 (en) * 2011-05-31 2012-11-20 Фатима Якубовна Богатырева Method of treating patients suffering infertility caused by polycystic ovarian disease of ovarian genesis with underlying chronic and acute pelvic inflammation
US9404908B2 (en) * 2013-04-29 2016-08-02 The Board of Truestees of the Leland Stanford Junior University Non-invasive imaging to the blastocyst stage for the detection of human embryonic aneuploidy
AU2016223496B2 (en) 2015-02-26 2021-09-09 Ferring B.V. Methods of treating infertility

Also Published As

Publication number Publication date
JP2020203904A (en) 2020-12-24
US20160250296A1 (en) 2016-09-01
US20200093893A1 (en) 2020-03-26
HRP20240013T1 (en) 2024-03-29
KR102618298B1 (en) 2023-12-26
CA2976032A1 (en) 2016-09-01
RS65096B1 (en) 2024-02-29
MA41758A (en) 2018-01-03
SI3261661T1 (en) 2024-03-29
CN107257690A (en) 2017-10-17
EP4289477A3 (en) 2024-02-21
US11679145B2 (en) 2023-06-20
PL3261661T3 (en) 2024-03-25
RU2017131129A3 (en) 2019-07-17
HUE064604T2 (en) 2024-04-28
KR20170123321A (en) 2017-11-07
LT3261661T (en) 2024-01-25
ZA201705489B (en) 2024-02-28
WO2016135221A1 (en) 2016-09-01
MX2017010320A (en) 2018-01-23
RU2723098C2 (en) 2020-06-08
PH12017501493A1 (en) 2018-01-29
HK1246655A1 (en) 2018-09-14
DK3261661T3 (en) 2024-01-15
EP3261661A1 (en) 2018-01-03
AU2016223496B2 (en) 2021-09-09
EP4289477A2 (en) 2023-12-13
US20240009278A1 (en) 2024-01-11
JP7163027B2 (en) 2022-10-31
JP2018511575A (en) 2018-04-26
US10413592B2 (en) 2019-09-17
AU2016223496A1 (en) 2017-08-10
CN113769069A (en) 2021-12-10
JP7157108B2 (en) 2022-10-19
EP3261661B1 (en) 2023-10-18
US20210093697A1 (en) 2021-04-01
ES2968102T3 (en) 2024-05-07
MD3261661T2 (en) 2024-04-30
FI3261661T3 (en) 2024-01-15
US11351228B2 (en) 2022-06-07
MA41758B1 (en) 2024-03-29
RU2017131129A (en) 2019-03-28

Similar Documents

Publication Publication Date Title
HK1251408A1 (en) Methods of treating cancer
IL260199B (en) Methods of treating cancer
IL285151B1 (en) Methods of treating fgf21-associated disorders
IL281293A (en) Methods of treating hyperalgesia
HK1244217A1 (en) Methods for treating proteinopathies
HK1246655A1 (en) Methods of treating infertility
IL256207B (en) Methods of treating multiple sclerosis
IL265696A (en) Methods of treating female infertility
GB201410116D0 (en) Method of treatment
HK1247818A1 (en) Method of treating diseases
PL3283097T3 (en) Fsh for treatment of infertility
GB201604627D0 (en) Improved method of FT-IMS
IL253028B (en) Method of treatment
GB201602802D0 (en) Method of treatment
HK1243937A1 (en) Methods of treating diseases
GB201512139D0 (en) Methods of treatment
PT3261661T (en) Methods of treating infertility
GB201511017D0 (en) Method of treatment
GB201421982D0 (en) Method of treatment
GB201421980D0 (en) Method of treatment
GB201415331D0 (en) Method of treatment
GB201414780D0 (en) Method Of Treatment